lintuzumab
matuzumab
onartuzumab
sibrotuzumab
dalotuzumab
inotuzumab ozogamicin
dacetuzumab
conatumumab
patritumab
mapatumumab
panitumumab
oleclumab
drozitumab
naptumomab estafenatox
tenatumomab
lexatumumab
samalizumab
apolizumab
sonepcizumab
elotuzumab
tucotuzumab
tigatuzumab
duligotuzumab
inotuzumab
fontolizumab
ocrelizumab
agonistic monoclonal antibody
cantuzumab
teprotumumab
ipilimumab
lucatumumab
bivatuzumab
adecatumumab
figitumumab
pamrevlumab
tabalumab
acrixolimab
nofetumomab
lenzilumab
avelumab
iratumumab
cergutuzumab
zalutumumab
pritumumab
mogamulizumab
labetuzumab
carlumab
durvalumab
ozogamicin
arcitumomab